158 related articles for article (PubMed ID: 14735191)
21. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
22. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Helo P; Cronin AM; Danila DC; Wenske S; Gonzalez-Espinoza R; Anand A; Koscuiszka M; Väänänen RM; Pettersson K; Chun FK; Steuber T; Huland H; Guillonneau BD; Eastham JA; Scardino PT; Fleisher M; Scher HI; Lilja H
Clin Chem; 2009 Apr; 55(4):765-73. PubMed ID: 19233911
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P
Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796
[TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection.
Wang J; Dong HY; Zhou Y; Han LY; Zhang T; Lin M; Wang C; Xu H; Wu ZS; Jia L
Biosens Bioelectron; 2018 Dec; 122():239-246. PubMed ID: 30267982
[TBL] [Abstract][Full Text] [Related]
26. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
27. Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients.
Ji JL; Jiang YZ; Tang QQ; He XD; Shen ZJ; Zhang BY
J Clin Lab Anal; 2016 Sep; 30(5):656-62. PubMed ID: 26987307
[TBL] [Abstract][Full Text] [Related]
28. Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.
Barić M; Kulić A; Sirotković-Skerlev M; Dedić Plavetić N; Vidović M; Horvatić-Herceg G; Vrbanec D
Pathol Oncol Res; 2015 Jul; 21(3):589-95. PubMed ID: 25367073
[TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
Chen CL; Mahalingam D; Osmulski P; Jadhav RR; Wang CM; Leach RJ; Chang TC; Weitman SD; Kumar AP; Sun L; Gaczynska ME; Thompson IM; Huang TH
Prostate; 2013 Jun; 73(8):813-26. PubMed ID: 23280481
[TBL] [Abstract][Full Text] [Related]
30. HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
Brouwer A; De Laere B; van Dam PJ; Peeters D; Van Haver J; Sluydts E; El Moussaoui A; Mendelaar P; Kraan J; Peeters M; Van Laere S; Dirix L
PLoS One; 2019; 14(9):e0220906. PubMed ID: 31483799
[TBL] [Abstract][Full Text] [Related]
31. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.
Fehm T; Becker S; Duerr-Stoerzer S; Sotlar K; Mueller V; Wallwiener D; Lane N; Solomayer E; Uhr J
Breast Cancer Res; 2007; 9(5):R74. PubMed ID: 17963511
[TBL] [Abstract][Full Text] [Related]
32. Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.
Chen BT; Loberg RD; Neeley CK; O'Hara SM; Gross S; Doyle G; Dunn RL; Kalikin LM; Pienta KJ
Urology; 2005 Mar; 65(3):616-21. PubMed ID: 15780403
[TBL] [Abstract][Full Text] [Related]
33. Her-2/neu expression in prostate cancer: a dynamic process?
Carles J; Lloreta J; Salido M; Font A; Suarez M; Baena V; Nogue M; Domenech M; Fabregat X
Clin Cancer Res; 2004 Jul; 10(14):4742-5. PubMed ID: 15269147
[TBL] [Abstract][Full Text] [Related]
34. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer.
Rubin SC; Finstad CL; Federici MG; Scheiner L; Lloyd KO; Hoskins WJ
Cancer; 1994 Mar; 73(5):1456-9. PubMed ID: 7906607
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
38. Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression.
Kolostova K; Pinterova D; Hoffman RM; Bobek V
Anticancer Res; 2011 May; 31(5):1535-9. PubMed ID: 21617207
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
Gu K; Mes-Masson AM; Gauthier J; Saad F
Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
